Safety and efficacy of glucagon-like peptide-1 (GLP-1) receptor agonists in patients with weight regain or insufficient weight loss after metabolic bariatric surgery: A systematic review and meta-analysis.
Quick Facts
What This Study Found
Key Numbers
How They Did This
Why This Research Matters
What This Study Doesn't Tell Us
Trust & Context
- Original Title:
- Safety and efficacy of glucagon-like peptide-1 (GLP-1) receptor agonists in patients with weight regain or insufficient weight loss after metabolic bariatric surgery: A systematic review and meta-analysis.
- Published In:
- Obesity reviews : an official journal of the International Association for the Study of Obesity, 25(11), e13811 (2024)
- Authors:
- Esparham, Ali, Mehri, Ali, Dalili, Amin, Richards, Jesse, Khorgami, Zhamak
- Database ID:
- RPEP-08167
Evidence Hierarchy
Read More on RethinkPeptides
Related articles coming soon.
Cite This Study
https://rethinkpeptides.com/research/RPEP-08167APA
Esparham, Ali; Mehri, Ali; Dalili, Amin; Richards, Jesse; Khorgami, Zhamak. (2024). Safety and efficacy of glucagon-like peptide-1 (GLP-1) receptor agonists in patients with weight regain or insufficient weight loss after metabolic bariatric surgery: A systematic review and meta-analysis.. Obesity reviews : an official journal of the International Association for the Study of Obesity, 25(11), e13811. https://doi.org/10.1111/obr.13811
MLA
Esparham, Ali, et al. "Safety and efficacy of glucagon-like peptide-1 (GLP-1) receptor agonists in patients with weight regain or insufficient weight loss after metabolic bariatric surgery: A systematic review and meta-analysis.." Obesity reviews : an official journal of the International Association for the Study of Obesity, 2024. https://doi.org/10.1111/obr.13811
RethinkPeptides
RethinkPeptides Research Database. "Safety and efficacy of glucagon-like peptide-1 (GLP-1) recep..." RPEP-08167. Retrieved from https://rethinkpeptides.com/research/esparham-2024-safety-and-efficacy-of
Access the Original Study
Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.
This study breakdown was produced by the RethinkPeptides research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.